Publicaciones (43) Publicaciones de ESTIBALIZ CASTILLERO OLABARRIA

2025

  1. Serotonin transporter deficiency in mice results in an increased susceptibility to HTR2B-dependent pro-fibrotic mechanisms in the cardiac valves and left ventricular myocardium

    Cardiovascular Pathology, Vol. 74

2024

  1. Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 84, Núm. 20, pp. 1999-2011

  2. Somatostatin receptors in fibrotic myocardium

    PLoS ONE, Vol. 19, Núm. 7 July

2023

  1. Decreased serotonin transporter activity in the mitral valve contributes to progression of degenerative mitral regurgitation

    Science Translational Medicine, Vol. 15, Núm. 677

  2. Implications of Bicuspid Aortic Valve Disease and Aortic Stenosis/Insufficiency as Risk Factors for Thoracic Aortic Aneurysm

    Reviews in Cardiovascular Medicine, Vol. 24, Núm. 6

  3. Polymeric prosthetic heart valves: A review of current technologies and future directions

    Frontiers in Cardiovascular Medicine, Vol. 10

2022

  1. Magnetic susceptibility and R2* of myocardial reperfusion injury at 3T and 7T

    Magnetic Resonance in Medicine, Vol. 87, Núm. 1, pp. 323-336

2021

  1. Altered Responsiveness to TGFβ and BMP and Increased CD45+ Cell Presence in Mitral Valves Are Unique Features of Ischemic Mitral Regurgitation

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 41, Núm. 6, pp. 2049-2062

2020

  1. Activin type II receptor ligand signaling inhibition after experimental ischemic heart failure attenuates cardiac remodeling and prevents fibrosis

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 318, Núm. 2, pp. H378-H390

  2. Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms

    Cardiovascular Pathology, Vol. 46

  3. Iron imaging in myocardial infarction reperfusion injury

    Nature Communications, Vol. 11, Núm. 1

  4. Mitral valve leaflet response to ischaemic mitral regurgitation: From gene expression to tissue remodelling

    Journal of the Royal Society Interface, Vol. 17, Núm. 166

2019

  1. Impairment of Myocardial Glutamine Homeostasis Induced by Suppression of the Amino Acid Carrier SLC1A5 in Failing Myocardium

    Circulation: Heart Failure, Vol. 12, Núm. 12

2018

  1. MicroRNA-195 regulates metabolism in failing myocardium via alterations in sirtuin 3 expression and mitochondrial protein acetylation

    Circulation, Vol. 137, Núm. 19, pp. 2052-2067

  2. Serum exosomal protein profiling for the non-invasive detection of cardiac allograft rejection

    Journal of Heart and Lung Transplantation, Vol. 37, Núm. 3, pp. 409-417

  3. Structural and functional cardiac profile after prolonged duration of mechanical unloading: Potential implications for myocardial recovery

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 315, Núm. 5, pp. H1463-H1476

2017

  1. Increased de novo ceramide synthesis and accumulation in failing myocardium

    JCI insight, Vol. 2, Núm. 14

  2. Increased de novo ceramide synthesis and accumulation in failing myocardium

    JCI Insight, Vol. 2, Núm. 9

2016

  1. Bridging Anticoagulation after Mechanical Aortic Heart Valve Replacement: A Questionable Routine

    Annals of Thoracic Surgery, Vol. 102, Núm. 1, pp. 48-54

2015

  1. Activation of pparδ signaling improves skeletal muscle oxidative metabolism and endurance function in an animal model of ischemic left ventricular dysfunction

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 308, Núm. 9, pp. H1078-H1085